Neumora Therapeutics (NMRA) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
NMRA is expected to report earnings to rise 75.68% to -64 cents per share on October 30
Q3'24
Est.
$-0.65
Q2'24
Beat
by $0.31
Q1'24
Beat
by $0.32
Q4'23
Missed
by $0.07
Q3'23
Missed
by $0.78
The last earnings report on August 06 showed earnings per share of -37 cents, beating the estimate of -68 cents. With 182.02K shares outstanding, the current market capitalization sits at 2.12B.